Stoke Therapeutics Stock Target Price and Analyst Consensus
| STOK Stock | USD 11.27 0.04 0.35% |
The current analyst and expert consensus on Stoke Therapeutics is Strong Buy, with 6 strong buy opinions. The current projected Stoke Therapeutics target price consensus is 22.00 with 9 analyst opinions. Check out Macroaxis Advice on Stoke Therapeutics to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. For more information on how to buy Stoke Stock please use our How to buy in Stoke Stock guide.The most common way Stoke Therapeutics analysts use to provide recommendation to the public is financial statements analysis. Many experts also interview Stoke Therapeutics executives and customers to further validate their buy or sell advice. Note, the total number of analysts currently providing their opinion is not significant to determine adequate consensus on Stoke Therapeutics. We strongly encourage you to use your own analysis of Stoke Therapeutics to validate this buy or sell advice. Stoke Therapeutics buy-or-sell recommendation module provides average expert sentiment on the projected Stoke Therapeutics target price to derive its highest and lowest estimates based on projected price volatility of 3.6966.
Lowest Forecast 20.02 | Highest Forecast 24.42 | Target Price 22 |
Stoke |
It's important to approach Stoke Therapeutics' target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
Stoke Therapeutics Target Price Consensus
Stoke target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. Stoke Therapeutics' target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
| 9 | Strong Buy |
Most Stoke analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand Stoke stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of Stoke Therapeutics, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice Exposure ValuationStoke Therapeutics Target Price Projection
Stoke Therapeutics' current and average target prices are 11.27 and 22.00, respectively. The current price of Stoke Therapeutics is the price at which Stoke Therapeutics is currently trading. On the other hand, Stoke Therapeutics' target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.Current Price
Stoke Therapeutics Market Quote on 22nd of November 2024
Target Price
Analyst Consensus On Stoke Therapeutics Target Price
Stoke Therapeutics Analyst Ratings
Stoke Therapeutics' analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about Stoke Therapeutics stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of Stoke Therapeutics' financials, market performance, and future outlook by experienced professionals. Stoke Therapeutics' historical ratings below, therefore, can serve as a valuable tool for investors.Analyst Consensus Breakdown
Average Consensus Estimates
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.
Steps to utilize Stoke Therapeutics price targets
Stoke Therapeutics' stock target price is an estimate of its future price, usually made by analysts. Using Stoke Therapeutics' target price to determine if it is a suitable investment can be done through the following steps:- Look at Stoke Therapeutics' target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
- Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
- Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
- Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if Stoke Therapeutics' stock is likely to perform well.
- Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Additional Stoke Therapeutics Value Projection Modules
Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Stoke Therapeutics is a key component of Stoke Therapeutics valuation and have some predictive power on the future returns of a Stoke Therapeutics.Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Driverless Cars Invested over 200 shares | |
 | Investor Favorites Invested few shares | |
 | Momentum Invested few shares | |
 | Business Services Invested few shares | |
 | Power Assets Invested over 200 shares | |
 | Hedge Favorites Invested over 40 shares | |
 | Social Domain Invested few shares | |
 | Housewares Invested few shares | |
 | Robots And Drones Sold few shares | |
 | Chemicals Invested over 30 shares | |
 | FinTech Invested over 40 shares | |
 | Macroaxis Index Invested few shares |
Check out Macroaxis Advice on Stoke Therapeutics to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. For more information on how to buy Stoke Stock please use our How to buy in Stoke Stock guide.You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.